BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4020358)

  • 1. Bronchogenic carcinoma and hypercalcemia.
    Lueg MC; Barkman HW
    J La State Med Soc; 1985 May; 137(5):66-70. PubMed ID: 4020358
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypercalcemia in bronchogenic carcinoma.
    Shankar PS
    J Assoc Physicians India; 1979 Jan; 27(1):19-25. PubMed ID: 511820
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum calcium in bronchial carcinoma: a population-based study.
    Gislason T; Palmér M; Nõu E
    Eur J Respir Dis; 1987 Jan; 70(1):8-13. PubMed ID: 3817068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary cyclic AMP as an aid in the differential diagnosis of hypercalcemia.
    Debacker M; Manderlier T; Nijs-Dewolf N; Six R; Corvilain J
    Biomedicine; 1974 Aug; 21(8):338-41. PubMed ID: 4374265
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum hCG in bronchogenic carcinoma.
    Behera D; Dash S; Malik SK; Dash RJ
    Indian J Chest Dis Allied Sci; 1984; 26(4):238-41. PubMed ID: 6545265
    [No Abstract]   [Full Text] [Related]  

  • 6. [Beta-2-microglobulin in bronchogenic carcinoma].
    Zatloukal P; Dudková V; Mĕricka O
    Sb Lek; 1990; 92(11-12):366-9. PubMed ID: 2136432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood lactate threshold in patients with bronchogenic carcinoma].
    Miyoshi S; Monden Y; Nakahara K; Ohno K; Fujii Y; Hashimoto J; Kitagawa Y; Kido T; Maeda H; Ikeda M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Jun; 24(6):618-24. PubMed ID: 3773366
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful combination chemotherapy for metastatic parathyroid carcinoma.
    Bukowski RM; Sheeler L; Cunningham J; Esselstyn C
    Arch Intern Med; 1984 Feb; 144(2):399-400. PubMed ID: 6696578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
    Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
    J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue polypeptide antigen in bronchogenic carcinoma.
    Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O
    Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercalcemia and bronchial carcinoma.
    CAREY VC
    Am Rev Respir Dis; 1962 Feb; 85():258-60. PubMed ID: 13876568
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypercalcemia in lithium therapy--an underestimated complication?].
    Kallner G; Lindelius R; Markiewicz P; Mathé A; Pettersson U; Nilsson CG
    Lakartidningen; 1992 Nov; 89(48):4163-4. PubMed ID: 1461037
    [No Abstract]   [Full Text] [Related]  

  • 13. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
    Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
    Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum hexosamine and its correlations with serum iron, copper, and iron-binding capacity in bronchogenic pulmonary carcinoma.
    Kokkola K; Tani P
    Scand J Respir Dis Suppl; 1972; 80():137-41. PubMed ID: 4510910
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum iron, copper, and iron-binding capacity in bronchogenic pulmonary carcinoma.
    Tani P; Kokkola K
    Scand J Respir Dis Suppl; 1972; 80():121-8. PubMed ID: 4510909
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevated prostaglandins and suppressed parathyroid hormone associated with hypercalcemia and renal cell carcinoma.
    Robertson RP; Baylink DJ; Marini BJ; Adkison HW
    J Clin Endocrinol Metab; 1975 Jul; 41(1):164-7. PubMed ID: 1150858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening and transcortin binding capacity of ectopic ACTH producing lung cancer].
    Kusama M; Abe O; Sakauchi N; Kumaoka S; Ishikawa S
    Gan No Rinsho; 1969 Oct; 15(10):859-65. PubMed ID: 4310775
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypercalcaemia induced by excessive parathyroid hormone secretion in a patient with a neuroendocrine tumour.
    Vacher-Coponat H; Opris A; Denizot A; Dussol B; Berland Y
    Nephrol Dial Transplant; 2005 Dec; 20(12):2832-5. PubMed ID: 16188904
    [No Abstract]   [Full Text] [Related]  

  • 19. Parathyroid hormone measurements in hyperparathyroidism and hypercalcemia due to nonparathyroid cancers.
    Lohrenz FN
    Wis Med J; 1971 Jun; 70(6):159-61. PubMed ID: 5561285
    [No Abstract]   [Full Text] [Related]  

  • 20. [Some biochemical possibilities for early bronchogenic carcinoma diagnosis].
    Procházka J; Kopecký P; Deyl Z; Svojtková E; Smíd A; Burian I
    Cas Lek Cesk; 1976 Oct; 115(41):1262-5. PubMed ID: 991175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.